PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
19485844 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | abacavir | NA | carbamazepine | NA | unclassified | |
NA | |||||||
19497038 | HLA (HLA) | drug hypersensitivity | Vietnamese | NA | NA | unclassified | |
frequency studies and a strong genetic association between hla subtypes and susceptibility to drug hypersensitivity have been reported in different ethnic populations. | |||||||
20110067 | HLA (HLA) | minocycline | African | doxycycline | NA | unclassified | |
NA | |||||||
21924464 | HLA (HLA) | drug hypersensitivity | NA | carbamazepine | NA | unclassified | |
using the strong hla predisposition in patients with cbz-induced sjs/ten as a model, we aimed to study the use of tcr repertoire in patients with drug hypersensitivity. | |||||||
21924464 | HLA-B*15 | drug hypersensitivity | NA | carbamazepine | NA | unclassified | |
this study establishes the key role of the tcr in the pathogenic mechanism of sjs/ten, explains why some hla-b*1502 carriers are tolerant to cbz, and provides a biomarker profile for drug hypersensitivity. | |||||||
21924464 | HLA-B*15 | drug hypersensitivities | NA | carbamazepine | NA | unclassified | |
despite the strong hla predisposition to drug hypersensitivities, such as hla-b*1502 to carbamazepine (cbz)-induced sjs/ten, it remains unknown whether particular t-cell receptors (tcrs) participate in recognition of small drug/peptide-hla complexes. | |||||||
22585534 | HLA-B*57 | drug hypersensitivity | NA | abacavir | NA | unclassified | |
the antiretroviral drug abacavir (abc) elicits severe drug hypersensitivity reactions in hla-b*5701(+) individuals. | |||||||
22617051 | HLA-B*57 | flucloxacillin | NA | didanosine | NA | unclassified | |
NA | |||||||
22617051 | HLA ASSOCIATED (HLA-ASSOCIATED) | flucloxacillin | NA | didanosine | NA | unclassified | |
NA | |||||||
22617051 | HLA-B*57 | flucloxacillin | NA | didanosine | NA | unclassified | |
NA |
Copyright 2024